Tulane and partners awarded next phase of MEASURE Evaluation

The United States Agency for International Development’s Bureau for Global Health awarded MEASURE Evaluation Phase IV to the University of North Carolina at Chapel Hill Carolina Population Center and its partners, Futures Group, ICF International, John Snow Incorporated, Management Sciences for Health, and Tulane University School of Public Health and Tropical Medicine.

Dr. Anastasia Gage

Dr. Anastasia Gage

The objective of MEASURE Evaluation Phase IV is to enable countries to strengthen their systems to generate high quality health information that is used for decision making at local, national, and global levels. The project will work to achieve this objective by concentrating on these four result areas:

  1. Strengthened collection, analysis, and use of routine health data
  2. Improved country-level capacity to manage health information systems, resources and staff
  3. Methods, tools, and approaches improved and applied to address health information challenges and gaps
  4. Increased capacity for rigorous evaluations

“We will respond to the complexity of this task by applying more systems thinking. There are many moving parts affecting each other and systems thinking provides ways to achieve progress in the midst of complexity,” said Project Director Jim Thomas.

Under MEASURE Evaluation Phase IV, Tulane University will provide leadership in evaluation research; health systems strengthening research; curriculum development and training; monitoring and evaluation of tuberculosis and malaria prevention and treatment programs; and costing of health interventions. The principal investigator of MEASURE Evaluation Phase IV for Tulane is Dr. Anastasia J. Gage, associate professor in the Department of Global Health Systems and Development.

MEASURE Evaluation Phase IV builds on USAID’s decades-long support to improve monitoring and evaluation (M&E) in the health sector. In this phase, more emphasis will be placed on strengthening the collection, analysis, and use of routine health information and on increasing local capacity for implementation of rigorous evaluation (including impact evaluation).

MEASURE Evaluation Phase IV is a five-year Leader with Associates Cooperative Agreement with a ceiling of $180 million, which will run through June 2019.


July 7, 2014



1440 Canal Street, New Orleans, LA 70112 504-988-5388 or 800-676-5389